Dr. Adrian Carter is an NHMRC Career Development and Senior Research Fellow and Head, Neuroethics and Public Policy Group at the School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University. He is also Director, Neuroethics Program, Australian Research Council Centre of Excellence for Integrative Brain Function and Chair, Australian Brain Alliance Neuroethics Subcommittee, Australian Academy of Science. His research examines the impact of neuroscience on our understanding and treatment of addiction and other compulsive behaviours, including: agency, identity, moral responsibility, the use of coercion and the capacity for voluntary control of addictive or compulsive behaviours; and the use of emerging technologies such as brain stimulation and neuroimaging, to treat addiction. He received the Australasian Professional Society of Alcohol and Other Drugs “Early Career Award for Excellence in Research and Science” (2012) and the Australian National Drug and Alcohol Award for Excellence in Research (2010). He has over 120 publications, including the book ‘Addiction Neuroethics: The Promises and Perils of Addiction Neuroscience’ (Cambridge University Press, 2012). Dr Carter has been an advisor to the World Health Organization, the European Monitoring Centre for Drugs and Drug Addiction, the Australian Ministerial Council on Drugs Strategy and United Nations Office on Drugs and Crime. He is also Deputy Chair of the Australian Academy of Science Early and Mid Career Research Forum Executive.
Tamami Fukushi is the Deputy Manager in the Department of Research Infrastructure at Japan’s Agency for Medical Research and Development (AMED). She is also the consultant for the Global Neuroethics Summit. She started her career in Neuroethics in 2005 at the Research Institute of Science and Technology for Society (RISTEX), Japan Science and Technology Agency (JST) after 10 years of research in neural control of movement. Her current interest is ELSI of advanced technology of neuroscience in the context of science policy and regulatory science. She recently published a book titled “Social Implementation of Nepourodegenerative Disease Research and Neuroethics” In: Wada, K., (ed.) Neurodegenerative Disorders as Systemic Diseases. Pp.295-304, Springer and “Neuroethics in Japan” In: Rommelfanger, K., (ed.) Handbooks in Neuroethics. Routledge.
Dr. Illes is the Professor of Neurology and Canada Research Chair in Neuroethics at the University of British Columbia. She is the Director of the National Core for Neuroethics at UBC, and faculty in the Centre for Brain Health at UBC and at the Vancouver Coastal Health Research Institute. She also holds affiliate appointments in the School of Population and Public Health and the School of Journalism at UBC, and in the Department of Computer Science and Engineering at the University of Washington in Seattle, WA. USA, and is a Life Member of Clare Hall, Cambridge University. Dr. Illes’ research focuses on ethical, legal, social and policy challenges specifically at the intersection of the sciences of the central nervous system and biomedical ethics. This includes empirical studies in stem cells and regenerative medicine, neurogenetics, brain injury, aging and neurodevelopmental disorders, mental health and addictions, and the commercialization of neuroscience and personalization of health. Her research results in actionable practical guidance, frameworks for empowering the ethical development and communication of science, and evidence for informed policy-making. She also leads a robust program of research and outreach devoted to improving public literacy about brain research and engaging stakeholders on a global scale.
Dr. Illes is the President of the International Neuroethics Society that she founded with others in 2006, and Vice Chair of the Standing Committee on Ethics for the Canadian Institutes of Health Research. She is a member of the Dana Alliance for Brain Initiatives and a Canadian representative to IBRO US-Canada Committee. Dr. Illes was elected to the Royal Society (Life Sciences) in 2012), to the Canadian Academy of Health Sciences in 2011, and to the American Association for the Advancement of Science (Neuroscience) in 2013. Her latest book (Oxford University Press, 2017) is Neuroethics: Anticipating the Future.
Jialin Charles Zheng
Jialin Zheng is Dean of the Tongji University School of Medicine, where he is a Professor of Neuroscience and Regenerative Medicine. He is simultaneously a Professor of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center (UNMC). Dr. Zheng’s research focuses on the understanding and treatment of neurodegenerative disorders such as Parkinson’s Disease. Ultimately it is the mission of his lab to develop drugs that will inhibit neurotoxin production and enhance neuronal repair in the brain. Dr. Zheng has been at the fore of UNMC’s collaborative efforts in China. He is the Director of UNMC’s Asia Pacific Rim Development Program and has worked to create more than 10 partnerships in China, including the formation of the first joint U.S./Chinese M.D./Ph.D. program. Dr. Zheng received his M.D. from Xuzhou Medical College in China and served as a visiting scholar at the State University of New York at Buffalo prior to joining UNMC.